|
KMID : 1100720230430050477
|
|
Annals of Laboratory Medicine
2023 Volume.43 No. 5 p.477 ~ p.484
|
|
|
Reducing Microbial Contamination in Hematopoietic Stem Cell Products and Quality Improvement Strategy: Retrospective Analysis of 1996-2021 Data
|
|
Kim Yong-Woo
Lee Jong-Kwon
Park Hye-Kyung
Han Ae-Kyung
Mun Sun-Kyoung
Park Hye-Jeong
Choung Hae-Kyoung
Kim Se-Mi
Choi Kwang-Mo
Lee Nam-Yong
Cho Duck
Kim Dae-Won
Kang Eun-Suk
|
|
|
Abstract
|
|
|
Background: Sterility and safety assurance of hematopoietic stem cell (HSC) products is critical in transplantation. Microbial contamination can lead to product disposal and increases the risk of unsuccessful clinical outcomes. Therefore, it is important to implement and maintain good practice guidelines and regulations for the HSC collection and processing unit in each hospital. We aimed to share our experiences and suggest strategies to improve the quality assurance of HSC processing.
Methods: We retrospectively analyzed microbial culture results of 11,743 HSC products processed over a 25-year period (January 1996 to May 2021). Because of reorganization of the HSC management system in 2008, the 25-year period was divided into periods 1 (January 1996 to December 2007) and 2 (January 2008 to May 2021). We reviewed all culture results of the HSC products and stored aliquot samples and collected culture results for peripheral blood and catheter samples.
Results: Of the 11,743 products in total, 35 (0.3%) were contaminated by microorganisms, including 19 (0.5%) of 3,861 products during period 1 and 16 (0.2%) of 7,882 products during period 2. Penicillium was the most commonly identified microorganism (15.8%) during period 1 and coagulase-negative Staphylococcus was the most commonly identified (31.3%) during period 2. HSC product contamination occurred most often during HSC collection and processing.
Conclusions: The contamination rate decreased significantly during period 2, when the HSC management system was reorganized. Our results imply that handling HSC products by trained personnel and adopting established protocols, including quality assurance programs, aid in decreasing the contamination risk.
|
|
|
KEYWORD
|
|
|
Hematopoietic stem cells, Microbial contamination, Microbial culture, Bacteremia, Catheter-associated contamination, Quality assurance
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|